These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3352497)

  • 1. [Biological effects of the intramuscular administration of 239Pu as affected by chelate therapy].
    Siniakov EG; Nifatov AP; Bazhin AG; Liubchanskiĭ ER
    Med Radiol (Mosk); 1988 Mar; 33(3):60-3. PubMed ID: 3352497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior and biological action of large amounts of 239Pu following intramuscular administration in rats undergoing long-term therapy with Zn- and Ca-DTPA].
    Siniakov EG; Bazhin AG; Liubchanskiĭ ER; Nifatov AP
    Radiobiologiia; 1987; 27(1):129-30. PubMed ID: 3469686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological action of 239Pu during intake by inhalation and complexon therapy with Zn or Ca DTPA under experimental conditions].
    Siniakov EG; Nifatov AP; Liubchanskiĭ ER; Bazhin AG
    Med Radiol (Mosk); 1988 May; 33(5):58-61. PubMed ID: 3374306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior and biological effect of 239Pu on entry into a skin abrasion].
    Bazhin AG; Liubchanskiĭ ER; Nifatov AN; Siniakov EG
    Med Radiol (Mosk); 1983 Feb; 28(2):46-51. PubMed ID: 6835046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumors in rats that have received pentacin after the administration of plutonium-239].
    Bukhtoiarova EM; Lemberg VK; Erokhin RA; Beliaev IuA
    Vopr Onkol; 1968; 14(8):71-6. PubMed ID: 5247174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior and biological action of 239Pu administered intramuscularly during complexon therapy].
    Bazhin AG; Liubchanskiĭ ER; Nifatov AP; Siniakov EG
    Radiobiologiia; 1984; 24(1):129-32. PubMed ID: 6709836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats.
    Volf V
    Health Phys; 1974 Jul; 27(1):152-3. PubMed ID: 4430623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impairment of immunity and long-term effects of 239Pu in rats].
    Kirillova EN; Revina VS; Sokolova SN
    Radiobiologiia; 1991; 31(3):357-60. PubMed ID: 1887001
    [No Abstract]   [Full Text] [Related]  

  • 9. [Removal of monomeric 239Pu from bones and liver by liposome-encapsulated pentacin].
    Smirnov AA; Beliaev IK; Ivannikov AT; Il'in LA
    Biull Eksp Biol Med; 1985 Oct; 100(10):431-3. PubMed ID: 4052611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination.
    Harrison JD; David AJ
    Radiat Res; 1979 Mar; 77(3):534-46. PubMed ID: 441257
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of DTPA treatments following the injection of particulate plutonium.
    Bruenger FW; Taylor DM; Taylor GN; Lloyd RD
    Int J Radiat Biol; 1991 Nov; 60(5):803-18. PubMed ID: 1680951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term effects of combined exposure to external 137Cs gamma-radiation and incorporated 239Pu].
    Buldakov LA; Levdik TI
    Radiobiologiia; 1984; 24(5):668-71. PubMed ID: 6390500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcomas among beagles exposed to 239Pu.
    Whittemore AS; McMillan A
    Radiat Res; 1982 Apr; 90(1):41-56. PubMed ID: 6950452
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing the cancer risk of 239Pu by chelation therapy.
    Jones CW; Mays CW; Taylor GN; Lloyd RD; Packer SM
    Radiat Res; 1986 Sep; 107(3):296-306. PubMed ID: 3749464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
    Levdik TI; Liubchanskii ER; Nifatov AP
    Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental background for prompt treatment with DTPA of 239Pu-contaminated wounds.
    Volf V
    Health Phys; 1974 Sep; 27(3):273-7. PubMed ID: 4436049
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution and toxicity of monomeric and polymeric 239Pu in immature and adult rats.
    Mahlum DD; Sikov MR
    Radiat Res; 1974 Oct; 60(1):75-88. PubMed ID: 10881701
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between dose of injected 239Pu and bone sarcoma mortality in young adult beagles.
    Peterson AV; Prentice RL; Marek P
    Radiat Res; 1982 Apr; 90(1):77-89. PubMed ID: 7063639
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
    Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
    Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Na3Zn- and Na3Ca-DTPA on the behavior and biological action of 239Pu on rats].
    Liubchanskiĭ ER; Nifatov AP; Okolelova NM; Siniakov EG
    Med Radiol (Mosk); 1985 Feb; 30(2):35-9. PubMed ID: 3918236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.